165 related articles for article (PubMed ID: 31872472)
1. Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy.
Kuiperij HB; Hondius DC; Kersten I; Versleijen AAM; Rozemuller AJM; Greenberg SM; Schreuder FHBM; Klijn CJM; Verbeek MM
Neuropathol Appl Neurobiol; 2020 Aug; 46(5):431-440. PubMed ID: 31872472
[TBL] [Abstract][Full Text] [Related]
2. MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
Marazuela P; Solé M; Bonaterra-Pastra A; Pizarro J; Camacho J; Martínez-Sáez E; Kuiperij HB; Verbeek MM; de Kort AM; Schreuder FHBM; Klijn CJM; Castillo-Ribelles L; Pancorbo O; Rodríguez-Luna D; Pujadas F; Delgado P; Hernández-Guillamon M
Acta Neuropathol Commun; 2021 Sep; 9(1):154. PubMed ID: 34530925
[TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
van den Berg E; Nilsson J; Kersten I; Brinkmalm G; de Kort AM; Klijn CJM; Schreuder FHBM; Jäkel L; Gobom J; Portelius E; Zetterberg H; Brinkmalm A; Blennow K; Kuiperij HB; Verbeek MM
J Alzheimers Dis; 2023; 92(2):467-475. PubMed ID: 36776062
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
6. Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy.
Jäkel L; De Kort AM; Stellingwerf A; Hernández Utrilla C; Kersten I; Vervuurt M; Vermeiren Y; Küsters B; Schreuder FHBM; Klijn CJM; Kuiperij HB; Verbeek MM
Acta Neuropathol Commun; 2024 Jun; 12(1):103. PubMed ID: 38915119
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
9. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
[TBL] [Abstract][Full Text] [Related]
10. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
11. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
De Kort AM; Kuiperij HB; Alcolea D; Kersten I; Versleijen AAM; Greenberg SM; Stoops E; Schreuder FHBM; Klijn CJM; Lleó A; Claassen JAHR; Verbeek MM
Alzheimers Res Ther; 2021 Sep; 13(1):160. PubMed ID: 34560885
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
16. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
17. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
J Neurochem; 2024 Feb; ():. PubMed ID: 38362804
[TBL] [Abstract][Full Text] [Related]
18. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
19. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
[TBL] [Abstract][Full Text] [Related]
20. Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease.
De Kort AM; Kuiperij HB; Kersten I; Versleijen AAM; Schreuder FHBM; Van Nostrand WE; Greenberg SM; Klijn CJM; Claassen JAHR; Verbeek MM
Alzheimers Dement; 2022 Oct; 18(10):1788-1796. PubMed ID: 34874603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]